Results 71 to 80 of about 160,518 (194)

Allergic bronchopulmonary aspergillosis mimicking miliary tuberculosis

Egyptian Journal of Chest Disease and Tuberculosis, 2018
Tuberculosis (TB) continues to be a major global health problem, especially in developing countries such as Indonesia. TB makes the individual more susceptible to other diseases caused by other microorganisms.
Gurmeet Singh, Nova B Fauzi, Alvina Widhani   +2 more
doaj   +1 more source

Aspergilloma as a Skull Base Tumor: A Case Report [PDF]

Caspian Journal of Neurological Sciences
Background: Aspergillosis is a fungus-related health problem that may include allergic reactions like allergic bronchopulmonary aspergillosis, which presents as upper and lower airway disease or chronic and invasive forms of fungal infection.
Sevil Nasirmohtaram, Azin Tabari, Mehdi Zeinalizadeh, Mohammadreza Salehi, Seyed Musa Sadr Hosseini   +4 more
doaj  

Pulmonary Exacerbations and Treatment in PCD: A Narrative Review

Pediatric Pulmonology, Volume 61, Issue 7, July 2026.
ABSTRACT Primary ciliary dyskinesia (PCD) is a rare genetic disorder that causes chronic lung disease. Patients with PCD often experience pulmonary exacerbations with worsening symptoms and lung function decline. This review provides an overview of the existing knowledge regarding the PEx in PCD and reveals understudied topics that should be addressed ...
Pinelopi Anagnostopoulou, Stephanie Thee, Panayiotis Kouis, Panayiotis Yiallouros   +3 more
wiley   +1 more source

Treatment of Infections Due to Aspergillus terreus Species Complex

Journal of Fungi, 2018
The Aspergillus terreus species complex is found in a wide variety of habitats, and the spectrum of diseases caused covers allergic bronchopulmonary aspergillosis, Aspergillus bronchitis and/or tracheobronchitis, and invasive and disseminated ...
Cornelia Lass-Flörl
doaj   +1 more source

Meaningful Criteria to Persons Living With Cystic Fibrosis and Their Healthcare Providers in Helping Determine Adjustments to Routine Clinical Follow‐Up

Pediatric Pulmonology, Volume 61, Issue 7, July 2026.
ABSTRACT Introduction Persons living with cystic fibrosis (PwCF) have experienced fewer exacerbations and symptom burden over the last decade, largely thanks to widespread uptake of highly effective modulator therapy (HEMT). With these advancements, there have been interest in the community regarding adjustments to the care model.
William R. Hunt, Christian Merlo, Ashley Keller, Karen Lowe, Kristin Riekert, James D. Finklea   +5 more
wiley   +1 more source

Current Practices and Variations Among Pediatric Severe Asthma Programs in the United States—The North American Severe Pediatric Asthma Consortium

Pediatric Pulmonology, Volume 61, Issue 7, July 2026.
ABSTRACT Background Severe and difficult to treat asthma in children is a complex condition causing significant morbidity and associated healthcare costs. While treatment guidelines exist for severe asthma, optimal treatment approaches for the pediatric population are less well established.
Kristina Gaietto, Nadia Krupp, Avani V. Shah, Erhan Ararat, Samantha H. Averill, Sachin Baxi, Matejka Cernelc‐Kohan, Jeffrey M. Chambliss, Heather De Keyser, Monica Federico, Bob Geng, Akilah A. Jefferson, Parisa Kaviany, Lila C. Kertz, Kirsten Kloepfer, Allyson Larkin, Sydney Leibel, Tanya Martinez‐Fernandez, Samira Naime, Robert D. Pesek, Dinesh K. Pillai, Deepa Rastogi, Katherine Rivera‐Spoljaric, Kristie R. Ross, Franziska J. Rosser, Tregony C. Simoneau, Jade Tam‐Williams, Kelan G. Tantisira, William Anderson, Jonathan M. Gaffin, Theresa W. Guilbert, Erick Forno   +31 more
wiley   +1 more source

Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis

, 2018
Moshe Ashkenazi,1,2 Saray Sity,2 Ifat Sarouk,1,2 Bat El Bar Aluma,1,2 Adi Dagan,1,2 Yael Bezalel,1,2 Lea Bentur3 Kris De Boeck,4 Ori Efrati1,2 1Pediatric Pulmonology and National CF Center,
Sarouk I, Bentur L, Bar Aluma BE, De Boeck K, Efrati O, Bezalel Y, Ashkenazi M, Sity S, Dagan A   +8 more
core  

A Case of Allergic Bronchopulmonary Aspergillosis With Bronchial Asthma.

, 2022
Allergic bronchopulmonary aspergillosis (ABPA) is a fungal hypersensitivity reaction in chronic lung diseases like bronchial asthma and cystic fibrosis.
Amedu, Oyovwike S, Rajpopat, Pratik Bharat, Hambolu, Eloho, Garg, Tulika, Fonseca, Ayesha, Desai, Brinda Niravkumar, Sajjad, Taha, Khan, Aadil, Abro, Sheeraz, Ejiyooye, Toluwalope F   +9 more
core   +1 more source

A case of allergic bronchopulmonary aspergillosis with atypical clinical presentation

, 2012
Allergic bronchopulmonary aspergillosis (ABPA) is a common hypersensitivity reaction to Aspergillus fumigatus in patients with asthma or cystic fibrosis. It is rarely reported in patients without asthma.
Karazincir, Sinem, Ozer, Burcin, Dikmen, Nursel, BALCI, ALİ, Genc, Sebahat Akoglu, Babayigit, Cenk   +5 more
core   +1 more source

A questionnaire-based study on the role of environmental factors in allergic bronchopulmonary aspergillosis

Lung India, 2014
Background and Aims: Allergic bronchopulmonary aspergillosis (ABPA) is an immunological disorder caused by hypersensitivity against Aspergillus fumigatus. The pathogenesis of ABPA remains unknown.
Ritesh Agarwal, Durga Devi, Dheeraj Gupta, Arunaloke Chakrabarti   +3 more
doaj   +1 more source